Sudan
Tuberculosis profile
| High HIV burden |
Population  2012 37 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 8 (3.3–15) 22 (9–40)
Mortality (HIV+TB only) 2.1 (1.9–2.5) 5.7 (5–6.7)
Prevalence  (includes HIV+TB) 77 (39–130) 207 (104–345)
Incidence  (includes HIV+TB) 42 (35–51) 114 (94–136)
Incidence (HIV+TB only) 4.3 (3.5–5.1) 12 (9.5–14)
Case detection, all forms (%) 44 (37–54)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 6 587 (36) Relapse 679 (39)
Smear-negative 5 604 (31) Treatment after failure 150 (9)
Smear-unknown / not done 1 344 (7) Treatment after default 640 (37)
Extrapulmonary 4 561 (25) Other 266 (15)
Other 0 (0)      
Total new 18 096   Total retreatment 1 735  
           
Other (history unknown) 0        
Total new and relapse 18 775   Total cases notified 19 831  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.8 1.5 1.3
Age < 15 232 1 514 723
Laboratories 2012
Smear (per 100 000 population) 0.8
Culture (per 5 million population) 0.1
Drug susceptibility testing (per 5 million population) 0.1
Is second-line drug susceptibility testing available? No
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 70   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 67  
Retreatment 55  
TB/HIV 2012 Number (%)
TB patients with known HIV status 3 070 (15)
HIV-positive TB patients 231 (8)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 0 (0)
HIV-positive TB patients on antiretroviral therapy (ART) 40 (17)
HIV-positive people screened for TB 1 348  
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 1.8 (0.1–3.4) 19 (7.4–31)
MDR-TB cases among notified pulmonary
TB cases
240 (14–460) 330 (130–540)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 43 (<1%) 129 (7%) 224
Laboratory-confirmed MDR-TB cases 18 69 116
Patients started on MDR-TB treatment     58
Financing TB control 2013
National TB programme budget (US$ millions) 5.9
% Funded domestically 1%
% Funded internationally 91%
% Unfunded 7%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-24 Data: www.who.int/tb/data